跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 388,823 条关于
“Psoriasis Area and Severity Index”
全部
388,823
临床试验
341,320
药物
4,439
机构
2,280
资讯
40,784
4年前
Brodalumab Improves Health-Related Quality of Life in Psoriasis Patients, Itching Remains a Challenge
去年
Study Links Higher Psoriasis Acceptance to Improved Clinical Outcomes and Quality of Life
去年
Oral JNJ-2113 Demonstrates Efficacy in Phase 3 Trials for Moderate-to-Severe Psoriasis
去年
Icotrokinra Shows Promise in Phase 3 Trials for Plaque Psoriasis
去年
Sun Pharma Discontinues Psoriasis and Eczema Drug SCD-044 After Phase 2 Trial Failures
4年前
Celltrion Pursues Adalimumab Interchangeability as Formycon Reports Positive Ustekinumab Biosimilar Data
3年前
Acelyrin's Izokibep Fails to Meet Primary Endpoint in Phase 2b/3 Psoriasis Trial, Stock Plummets
去年
JNJ-2113 Shows Promise for Psoriasis, Infigratinib for Achondroplasia, and Gildeuretinol Gains FDA Support for Stargardt Disease
去年
JNJ-2113 Demonstrates Significant Skin Clearance in Phase 3 Psoriasis Trials
去年
Deucravacitinib Demonstrates Efficacy for Scalp and Overall Psoriasis in Phase 3 and Real-World Studies
第 1 页，共 4079 页
上一页
下一页
